| Financial Year |
March 31 2023 |
| Monetary Funds |
3,335,347,905.13 |
| Held-for-trading Financial Assets |
199,544,548.78 |
| Notes Receivable |
1,254,851,005.64 |
| Accounts Receivable |
19,713,131,244.74 |
| Advances to Suppliers |
821,003,974.04 |
| Other Receivables |
1,976,127,219.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,602,579.12 |
| Inventories |
4,059,004,107.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
371,843,062.54 |
| Other Current Assets |
144,821,117.14 |
| Total Current Assets |
32,051,719,445.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
14,731,973.59 |
| Long-term Equity Investment |
214,768,033.04 |
| Investment Properties |
82,557,224.64 |
| Fixed Assetes |
1,129,169,868.92 |
| Under-construction Projects |
38,279,613.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
401,008,148.64 |
| R&D expenses |
114,160,215.37 |
| Goodwill |
1,745,538,435.25 |
| Long-Term Deferred and Prepaid Expenses |
40,658,002.86 |
| Deferred Income Tax Assets |
387,649,689.42 |
| Other Non-Current Assets |
138,634,440.76 |
| Sub-Total of Non-Current Assets |
4,676,354,436.13 |
| Total Assets |
36,728,073,881.49 |
| Short-Term Loans |
11,979,237,816.28 |
| Trading Financial liabilities |
221,800,695.79 |
| Notes Payable |
2,219,377,451.24 |
| Accounts Payable |
7,976,771,100.23 |
| Accounts Received In Advance |
3,245,396.99 |
| Employee Compensation Payable |
90,063,109.79 |
| Taxes Payable |
264,198,131.24 |
| Interest Payable |
-- |
| Dividend Payable |
104,351,556.12 |
| Other payables |
6,176,220,199.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
213,624,945.24 |
| Other Current Liabilities |
375,216,185.55 |
| Sub-Total of Current Liabilities |
30,163,463,620.09 |
| Long-term Loans |
259,524,976.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
8,603,292.60 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,233,480.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
398,585,352.38 |
| Total Liabilities |
30,562,048,972.47 |
| Paid-In Capital(Or Share Stock) |
2,750,833,257.00 |
| Capital Surplus |
2,214,518,980.90 |
| Surplus Reserve |
52,141,669.22 |
| LESS:Treasury Stock |
275,118,243.17 |
| Undistributed Profits |
32,843,581.01 |
| Minority Stockholder's Interest |
1,410,178,714.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,755,846,194.56 |
| Owner's Equity（Stockholder's Equity） |
6,166,024,909.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
36,728,073,881.49 |
